Claris Lifesciences soars on buyback approval
The Claris Lifesciences scrip gained more than 8% intra-day after the drugmaker said that equity shareholders of the company had approved a R231-crore buyback. ?Equity shareholders of the company have approved the buyback of up to 92.50 lakh shares,? the company said in an exchange filing on Friday. The buyback has been priced at R250. The scrip ended 0.69% higher at R181.60 on Friday on the BSE.
Special trading session at NSE, BSE today
The Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) will conduct a special live trading session on Saturday as the NSE is testing its software. Trading will take place from 11.15 am to 12.45 pm.
Sebi slaps R20-lakh fine on two firms
Sebi has slapped a total fine of R20 lakh on two entities, Luharuka Commotrade and Comfort Fincap, for allegedly violating provisions of securities law. Sebi, in two separate orders, said that it has imposed penalty of R10 lakh each on the two entities for violating provisions SAST (Substantial Acquisition of Shares and Takeovers) regulations.
SAT upholds Sebi order in Aditya International case
The Securities Appellate Tribunal (SAT) on Friday upheld a Sebi order against an individual in a case of fraudulent dealings in the shares of Aditya International. In 2013, Sebi had imposed a penalty of R5 lakh on Saumil Bhavnagari for his involvement in price manipulation in the company?s scrip on many instances. Bhavnagari approached SAT challenging the ruling.
Citibank ties up with Apollo Munich
Citibank India has collaborated with Apollo Munich to provide specialised health care services to the over 16 million urban household customers in eight cities. The services will combine financial protection as well as health and lifestyle management support for non-communicable diseases such as hypertension, diabetes, heart disease, cancers and tumors.